07/21/2025
8:27 AM | Protalix BioTherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/03/2025
3:30 PM | Elze Christian (Reporting)
Protalix BioTherapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/26/2025
3:30 PM | Protalix BioTherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2025
5:57 AM | Protalix BioTherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2025
6:04 AM | Protalix BioTherapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/08/2025
3:30 PM | Protalix BioTherapeutics (Filer)
| Form ARS | |
04/28/2025
4:00 PM | Protalix BioTherapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
04/23/2025
3:30 PM | Protalix BioTherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/17/2025
4:19 PM | Protalix BioTherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/17/2025
6:18 AM | Protalix BioTherapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/17/2025
5:55 AM | Protalix BioTherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/31/2024
3:30 PM | Protalix BioTherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/23/2024
6:01 AM | Protalix BioTherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
6:03 AM | Protalix BioTherapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/14/2024
5:57 AM | Protalix BioTherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/05/2024
4:00 PM | Protalix BioTherapeutics (Issuer)
Rubin Eyal (Reporting)
| Form 4/A | |
10/25/2024
3:23 PM | Protalix BioTherapeutics (Subject)
WHITEBOX ADVISORS LLC (Filed by)
| Form SC 13G/A | |
10/25/2024
7:27 AM | Protalix BioTherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/24/2024
4:00 PM | Naos Yaron (Reporting)
Protalix BioTherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/24/2024
4:00 PM | Protalix BioTherapeutics (Issuer)
Rubin Eyal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
6:02 AM | Protalix BioTherapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/14/2024
5:56 AM | Protalix BioTherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Free PLX Stock Alerts